What is it about?

A possible relationship between endocan levels in stable COPD and the exacerbation frequency of patients.

Featured Image

Read the Original

This page is a summary of: Serum endocan levels in patients with chronic obstructive pulmonary disease: a potential role in the evaluation of susceptibility to exacerbation, Clinical Chemistry and Laboratory Medicine (CCLM), November 2018, De Gruyter,
DOI: 10.1515/cclm-2018-0331.
You can read the full text:

Read

Contributors

The following have contributed to this page